Literature DB >> 36171363

The psychedelic remedy for chronic pain.

Clare Watson.   

Abstract

Entities:  

Keywords:  Drug discovery; Medical research; Therapeutics

Mesh：

Substances：

Year:  2022        PMID： 36171363     DOI： 10.1038/d41586-022-02878-3

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  4 in total

1.  Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting.

Authors:  Elena Argento; M Eugenia Socias; Kanna Hayashi; JinCheol Choi; Lindsay Mackay; Devon Christie; M-J Milloy; Kora DeBeck
Journal:  Int J Drug Policy       Date:  2021-11-07

2.  Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

Authors:  Robin L Carhart-Harris; David Erritzoe; Tim Williams; James M Stone; Laurence J Reed; Alessandro Colasanti; Robin J Tyacke; Robert Leech; Andrea L Malizia; Kevin Murphy; Peter Hobden; John Evans; Amanda Feilding; Richard G Wise; David J Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

3.  Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.

Authors:  Emmanuelle A D Schindler; R Andrew Sewell; Christopher H Gottschalk; Christina Luddy; L Taylor Flynn; Hayley Lindsey; Brian P Pittman; Nicholas V Cozzi; Deepak C D'Souza
Journal:  Neurotherapeutics       Date:  2020-11-12       Impact factor: 7.620

4.  Emotions and brain function are altered up to one month after a single high dose of psilocybin.

Authors:  Frederick S Barrett; Manoj K Doss; Nathan D Sepeda; James J Pekar; Roland R Griffiths
Journal:  Sci Rep       Date:  2020-02-10       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.